NLA Nasal Spray - Meda
Alternative Names: NCX-1510; Nitric oxide-releasing cetirizine liposomal - Orexo; NLA; NO-releasing cetirizine liposomal - Orexo; OX-NLALatest Information Update: 29 Oct 2021
At a glance
- Originator NicOx
- Developer Meda
- Class Acetic acids; Antiallergics; Benzyl compounds; Chlorobenzenes; Eye disorder therapies; Nonsedating antihistamines; Piperazines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis